Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions.
52W Range
68thpctl
Volume
0.44×avg
Market Cap
1.29BUSD
P/E Ratio
-14.6TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Seaport Therapeutics, Inc. Common Stock
SPTXNASDAQ Global Market·USD·Closed
Seaport Therapeutics, Inc. Common Stock
SPTXNASDAQ·USD·Closed
$24.04
−8.42%
$24.04
−$2.21 (8.42%)
52W Range
68thpctl
Volume
0.44×avg
Mkt Cap
1.29BUSD
P/E
-14.6TTM
Div Yield
–ann
SPTX: Seaport Therapeutics, Inc. Common Stock Stock Analysis | finqOS
